127 related articles for article (PubMed ID: 37994193)
41. Surface display of heme- and diflavin-containing cytochrome P450 BM3 in Escherichia coli: a whole cell biocatalyst for oxidation.
Yim SK; Kim DH; Jung HC; Pan JG; Kang HS; Ahn T; Yun CH
J Microbiol Biotechnol; 2010 Apr; 20(4):712-7. PubMed ID: 20467243
[TBL] [Abstract][Full Text] [Related]
42. Tryptophan-96 in cytochrome P450 BM3 plays a key role in enzyme survival.
Ravanfar R; Sheng Y; Gray HB; Winkler JR
FEBS Lett; 2023 Jan; 597(1):59-64. PubMed ID: 36250256
[TBL] [Abstract][Full Text] [Related]
43. Expression of Synthetic cyp102A1-LG23 Gene and Functional Analysis of Recombinant Cytochrome P450 BM3-LG23 in the Actinobacterium Mycolicibacterium smegmatis.
Poshekhontseva VY; Strizhov NI; Karpov MV; Nikolaeva VM; Kazantsev AV; Sazonova OI; Shutov AA; Donova MV
Biochemistry (Mosc); 2023 Sep; 88(9):1347-1355. PubMed ID: 37770401
[TBL] [Abstract][Full Text] [Related]
44. Switching pyridine nucleotide specificity in P450 BM3: mechanistic analysis of the W1046H and W1046A enzymes.
Neeli R; Roitel O; Scrutton NS; Munro AW
J Biol Chem; 2005 May; 280(18):17634-44. PubMed ID: 15710617
[TBL] [Abstract][Full Text] [Related]
45. Engineering a self-sufficient Mycobacterium tuberculosis CYP130 by gene fusion with the reductase-domain of CYP102A1 from Bacillus megaterium.
Ortega Ugalde S; Luirink RA; Geerke DP; Vermeulen NPE; Bitter W; Commandeur JNM
J Inorg Biochem; 2018 Mar; 180():47-53. PubMed ID: 29232638
[TBL] [Abstract][Full Text] [Related]
46. Flavocytochrome P450 BM3: an update on structure and mechanism of a biotechnologically important enzyme.
Warman AJ; Roitel O; Neeli R; Girvan HM; Seward HE; Murray SA; McLean KJ; Joyce MG; Toogood H; Holt RA; Leys D; Scrutton NS; Munro AW
Biochem Soc Trans; 2005 Aug; 33(Pt 4):747-53. PubMed ID: 16042591
[TBL] [Abstract][Full Text] [Related]
47. Structural analysis of Cytochrome P450 BM3 mutant M11 in complex with dithiothreitol.
Frydenvang K; Verkade-Vreeker MCA; Dohmen F; Commandeur JNM; Rafiq M; Mirza O; Jørgensen FS; Geerke DP
PLoS One; 2019; 14(5):e0217292. PubMed ID: 31125381
[TBL] [Abstract][Full Text] [Related]
48. Insights into electron leakage in the reaction cycle of cytochrome P450 BM3 revealed by kinetic modeling and mutagenesis.
Lim JB; Barker KA; Eller KA; Jiang L; Molina V; Saifee JF; Sikes HD
Protein Sci; 2015 Nov; 24(11):1874-83. PubMed ID: 26311413
[TBL] [Abstract][Full Text] [Related]
49. Structure, electronic properties and catalytic behaviour of an activity-enhancing CYP102A1 (P450(BM3)) variant.
Whitehouse CJ; Yang W; Yorke JA; Tufton HG; Ogilvie LC; Bell SG; Zhou W; Bartlam M; Rao Z; Wong LL
Dalton Trans; 2011 Oct; 40(40):10383-96. PubMed ID: 21603690
[TBL] [Abstract][Full Text] [Related]
50. Effect of the Insertion of a Glycine Residue into the Loop Spanning Residues 536-541 on the Semiquinone State and Redox Properties of the Flavin Mononucleotide-Binding Domain of Flavocytochrome P450BM-3 from Bacillus megaterium.
Chen HC; Swenson RP
Biochemistry; 2008 Dec; 47(52):13788-99. PubMed ID: 19055322
[TBL] [Abstract][Full Text] [Related]
51. The Versatile Biocatalyst of Cytochrome P450 CYP102A1: Structure, Function, and Engineering.
Sun Y; Huang X; Osawa Y; Chen YE; Zhang H
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513226
[TBL] [Abstract][Full Text] [Related]
52. Molecular Lego of Human Cytochrome P450: The Key Role of Heme Domain Flexibility for the Activity of the Chimeric Proteins.
Catucci G; Ciaramella A; Di Nardo G; Zhang C; Castrignanò S; Gilardi G
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408976
[TBL] [Abstract][Full Text] [Related]
53. A novel semi-biosynthetic route for artemisinin production using engineered substrate-promiscuous P450(BM3).
Dietrich JA; Yoshikuni Y; Fisher KJ; Woolard FX; Ockey D; McPhee DJ; Renninger NS; Chang MC; Baker D; Keasling JD
ACS Chem Biol; 2009 Apr; 4(4):261-7. PubMed ID: 19271725
[TBL] [Abstract][Full Text] [Related]
54. Modulation of the interaction between human P450 3A4 and B. megaterium reductase via engineered loops.
Castrignanò S; D'Avino S; Di Nardo G; Catucci G; Sadeghi SJ; Gilardi G
Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):116-125. PubMed ID: 28734977
[TBL] [Abstract][Full Text] [Related]
55. Role of residue 87 in substrate selectivity and regioselectivity of drug-metabolizing cytochrome P450 CYP102A1 M11.
Vottero E; Rea V; Lastdrager J; Honing M; Vermeulen NP; Commandeur JN
J Biol Inorg Chem; 2011 Aug; 16(6):899-912. PubMed ID: 21567268
[TBL] [Abstract][Full Text] [Related]
56. Structural and spectroscopic characterization of P450 BM3 mutants with unprecedented P450 heme iron ligand sets. New heme ligation states influence conformational equilibria in P450 BM3.
Girvan HM; Seward HE; Toogood HS; Cheesman MR; Leys D; Munro AW
J Biol Chem; 2007 Jan; 282(1):564-72. PubMed ID: 17077084
[TBL] [Abstract][Full Text] [Related]
57. Mapping protein-protein interactions in homodimeric CYP102A1 by crosslinking and mass spectrometry.
Felker D; Zhang H; Bo Z; Lau M; Morishima Y; Schnell S; Osawa Y
Biophys Chem; 2021 Jul; 274():106590. PubMed ID: 33894563
[TBL] [Abstract][Full Text] [Related]
58. Molecular Determinants of Substrate Affinity and Enzyme Activity of a Cytochrome P450
Geronimo I; Denning CA; Heidary DK; Glazer EC; Payne CM
Biophys J; 2018 Oct; 115(7):1251-1263. PubMed ID: 30224054
[TBL] [Abstract][Full Text] [Related]
59. Optimization of the bacterial cytochrome P450 BM3 system for the production of human drug metabolites.
Di Nardo G; Gilardi G
Int J Mol Sci; 2012 Nov; 13(12):15901-24. PubMed ID: 23443101
[TBL] [Abstract][Full Text] [Related]
60. Generation of human metabolites of 7-ethoxycoumarin by bacterial cytochrome P450 BM3.
Kim DH; Kim KH; Kim DH; Liu KH; Jung HC; Pan JG; Yun CH
Drug Metab Dispos; 2008 Nov; 36(11):2166-70. PubMed ID: 18669587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
